Gastroenterology & Hepatology

A surgeon at work

Division of Gastroenterology & Hepatology

We focus on the prevention, diagnosis and treatment of gastrointestinal tract and liver diseases.

Leaders in the Field

The U-M Medical School Department of Internal Medicine Division of Gastroenterology and Hepatology has had a long history of excellence since 1947 that continues today. With 92 faculty, 23 fellows and over 150 staff, we are one of the largest gastroenterology practices in the country and a leader in the prevention, diagnosis and treatment of all diseases of the gastrointestinal system, from simple to complex, including those of the esophagus, stomach, small intestine, colon, rectum, liver, gallbladder, pancreas and biliary tract.

About

Learn more about the groundbreaking research, training and patient care in the Division of Gastroenterology & Hepatology.

Education

We offer three unique fellowship programs designed to prepare fellows for successful careers in gastroenterology and hepatology clinical care and research.

Research

In addition to being leaders in the clinic, our faculty are also leaders in their respective areas of research.

Faculty

See a list of the diverse faculty who guide our clinical, research and educational programs on the path to excellence.

Patient Care

Discover why we provide the highest quality of care and cutting-edge therapeutics at our clinical centers.

Giving

Your gift can help support patient care-related activities, nursing education and numerous research areas.

GI Hepatology lab

Join Our Team

The Division of Gastroenterology and Hepatology welcomes board certified candidates for faculty positions who have a commitment to outstanding patient care and endoscopic practice with an interest in teaching, academic medicine and scholarship.

Join Us

Welcome from the Division Chief

Dr. William Chey shares why our Division of Gastroenterology & Hepatology is a national leader in the field. From state-of-the-art clinical care for referring providers to world-class mentorship for trainees, see how we are advancing the future of digestive and liver health.
Badge with text: Best Hospitals U.S. News & World Report, Gastroenterology & GI Surgery 2025-2026

Nationally Ranked in Gastroenterology & GI Surgery

U-M Health has been recognized as one of the nation's top hospitals for gastroenterology and GI surgery by U.S. News & World Report for 2025-2026. 

Learn more about our U.S. News rankings

See Where Training Takes Place

Expand your career trajectory in a high-volume academic medical center that also supports and excels in a wide range of basic science, translational and clinical research programs.

See Training Locations

CME Courses

View a list of upcoming Continuing Medical Education (CME) opportunities available through the Department of Internal Medicine.

Stay Connected With Internal Medicine

Featured News & Stories

 See all news particles forming colorful in intestines
Health Lab

IBS treatment response predicted by gut microbiome in new study

A Michigan Medicine study finds the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D).
 red cells clustered together inside body black light up blue see through
Health Lab

Understanding esophageal cancer

In this Q&A, a Michigan Medicine doctor talks about esophageal cancer, its signs and risk factors to know.
 Man in a blue pullover against the background of Michigan Stadium
Health Lab

Thriving after a rectal cancer diagnosis

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.
 close up microscopic grey close up
Health Lab

FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues

University of Michigan researchers found that the FDA-approved drug fedratinib can lead to endoplasmic reticulum and mitochondria contact site formation, providing a potential therapeutic avenue.
 intestines red with red dot
Health Lab

Colorectal cancer is no longer just a disease of older adults

With colorectal (CRC) on the rise in younger patients, a specialist in gastroenterology and human genetics discusses why that may be and what to look for.
 microscope drawing yellow navy
Health Lab

Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth

University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.

Gastroenterology & Hepatology Internal Website

Resources and information for current GI & Hepatology faculty, staff and learners.

Gastroenterology & Hepatology Intranet